Stock Market News

Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF), a biotechnology firm specialising in allergy treatments, is showcasing key research findings at the European Academy of Allergy and Clinical Immunology (EAACI) Congress in Glasgow. Highlights include promising initial results from its peanut allergy vaccine candidate, which demonstrated safety and a significant reduction in allergic reactions in early human trials.

MP Evans Group PLC (AIM:MPE), a major producer of sustainable palm oil in Indonesia, reported an 11% increase in crop harvest from its plantations for the first five months of 2025, ahead of its annual meeting in London. The company harvested 521,400 tonnes of fresh fruit bunches, up from 468,000 tonnes during the same period in 2024.

Relying solely on past performance for Emerging Markets can be misleading when making portfolio decisions. Comparing Emerging Markets to US Total Market indices highlights significant performance and risk differences. Factor analysis tools reveal that Emerging Markets offer several benefits like equity-bond like correlation factors and periods of upside.

Tesla said on Thursday it upgraded its Model S and Model X cars in the U.S. and raised their prices by $5,000, according to the electric vehicle maker's post on X and its website.

DAX under pressure as inflation fears grow on rising oil prices. Market sentiment hinges on ECB signals and Middle East developments.

GSK said on Friday the European Medicines Agency had accepted the drugmaker's application to expand the use of its respiratory syncytial virus vaccine, Arexvy, to include adults from 18 years of age.

Vietnam's newly established Sun PhuQuoc Airways will initially operate Airbus's narrow-body aircraft, including the A321neo, it said on Friday.

Gold and crude oil prices rose after Israeli airstrikes targeted Iran's nuclear facilities and military leadership, fuelling fears of wider conflict in the Middle East. In early trading, the yellow metal was up 1.3% at $3,446.20, while Brent jumped 6% to $70.59.

I seeded my son's UTMA account with STRK, Strategy's convertible preferred stock, for its blend of yield, downside protection, and equity-like upside. STRK offers a high-yield income stream, the potential for capital appreciation, and a lower downside risk profile than MSTR, making it a compelling option for a portfolio. Some risks include Bitcoin volatility, capital structure changes, and possible dividend deferral, but STRK sits higher in the capital stack than Strategy's common equity and STRD.

Amena Bakr, Head of Middle East & OPEC+ Insights from Kpler, joins CNBC's Dan Murphy on Access Middle East to discuss the global impact of Israel's strikes on Iran and disruption to the oil market.